Papers
3
Total Citations
107
H-Index
2
About
Azik Hoffman is a urologic surgeon and researcher whose work centers on improving the diagnosis and surgical management of prostate, kidney, and bladder cancers. His most influential study, cited over 100 times, investigates the role of PSA density in stratifying prostate cancer risk, demonstrating how prostate volume impacts the detection of clinically significant disease—a contribution that helps reduce unnecessary biopsies and overtreatment. Hoffman has also advanced surgical safety in nephron-sparing procedures, evaluating the efficacy of biological hemostatic agents like Starsil® in robotic partial nephrectomy to minimize perioperative bleeding. More recently, his research on robotic radical cystectomy examines how neoadjuvant chemotherapy affects short-term surgical outcomes in bladder cancer patients, providing critical data for treatment planning. With a growing citation footprint and a focus on evidence-based, patient-centered urologic oncology, Hoffman’s work bridges the gap between diagnostic precision and surgical innovation, offering practical insights for clinicians managing complex genitourinary malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3